MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

The US Food and Drug Administration (FDA) has approved Ocugen’s investigational new drug (IND) amendment to initiate a Phase ...

Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc ...

FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Market Growth Driven by Rising Demand for Biopharmaceuticals, Precision Medicine Development, Biotechnology R&D Investments, ...

Karin Pelka is the 2025 recipient of the AAAS Martin and Rose Wachtel Cancer Research Award for her work with these critical multicellular networks.

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston ...